Position in ABBV
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$4,412,507
+$482,463 QoQ
Shares Held
17,535
-3.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#1,392
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026McAdam, LLC holds $23,291,732 across 9 Drug Manufacturers - General names. ABBV ranks #3 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,221 | $5,643,467 | |
| 2 | LLY |
ELI LILLY & Co
|
4,144 | $4,970,438 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
17,535 | $4,412,507 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,372 | $3,260,302 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
25,513 | $3,223,312 | |
| 6 | PFE |
Pfizer Inc
|
27,456 | $661,140 | |
| 7 | AMGN |
Amgen Inc
|
1,375 | $497,915 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,403 | $368,940 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,412,507 | 17,535 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $3,930,044 | 18,070 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,620,195 | 15,844 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,451,313 | 10,587 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,895,551 | 10,212 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $3,299,101 | 15,746 | Shares | Sole | 2025-05-21 | |
| 2024-12-31 | $3,093,401 | 17,408 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $3,431,609 | 17,377 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $2,953,745 | 17,221 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $3,111,542 | 17,087 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $2,648,902 | 17,093 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,581,719 | 17,320 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $2,304,017 | 17,101 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $3,399,043 | 21,328 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $2,094 | 15,467 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $2,289,219 | 17,057 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,513,661 | 16,412 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $2,518,703 | 15,537 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $2,094,231 | 15,467 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $1,665,728 | 15,442 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $1,734,656 | 15,400 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $958,504 | 8,857 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $972,064 | 9,072 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $774,470 | 8,842 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $789,956 | 8,046 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $583,996 | 7,665 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||